Assuming that biological or genetic differences relate directly to racial or ethnic categories can lead to false scientific conclusions and perpetuate bias. Misuse of population descriptors has harmed marginalized groups and promoted scientific racism. These limitations in existing population descriptors in genetics and genomics led 14 NIH Institutes, Centers, and Offices to sponsor the National Academies of Science, Engineering, and Medicine (NASEM) to establish an interdisciplinary committee of experts and explore the issue.
Earlier this month, we released a Request for Information seeking public input on the humane care and use of laboratory cephalopods at Assured institutions. The proposed guidance acknowledges the evidence suggesting these animals would benefit from oversight, but also that there are not yet specific care and use standards to allow them to be regulated under the Public Health Service Policy for the Humane Care and Use of Laboratory Animals.
We released our final Guide Notice clarifying NIH’s long-standing policy on foreign subaward and consortium written agreements. Here, we talk about the origins of this notice, consideration of and changes made in response to public comment, the final oversight and compliance requirements, and how these efforts will ensure NIH remains a proper steward of taxpayer support.
Applications for Fiscal Year (FY) 2024 NIH Loan Repayment Program (LRP) awards will open on September 1, 2023. LRPs can repay up to $100,000 of qualified educational debt for those who are eligible and agree to perform NIH mission-relevant research. The deadline to submit an application is November 16, 2023.
As part of proper stewardship of taxpayer funds, we at NIH are obligated, both legally and ethically, to ensure the welfare and reduce risks for those involved in our supported research activities. This obligation includes research animals. Their humane care and use is something we take very seriously. Today we are taking some time to touch upon our policies to protect animal welfare, discuss how we process reports of noncompliance, and provide resources to help recipients and researchers ensure their work involving animals is conducted appropriately.
As NIH has been emphasizing for more than a decade, the rigor and transparency of a study are key for gleaning the robustness of its results. This includes the design, implementation, analysis, and interpretation of experiments.
Sheila Garrity, JD, MPH, MBA, began as director of the HHS Office of Research Integrity (ORI) in March. As our offices work closely together to address research misconduct in NIH-funded biomedical research, we recently took some time to sit down and chat to get to know her better and welcome her to this new role.
Case Study in Research Integrity – Banned From Supervising, Can’t Go in Lab, but No Impact on NIH Funded Research?
We have seen rising numbers of allegations related to harassment, discrimination, and hostile work environments since 2018 (when we first started tracking them). In many cases, we successfully work with recipient institutions to put appropriate measures in place to address unsafe working environments. However, too often we hear from institutions that a PI has violated the institution’s policies and is no longer permitted to supervise students or staff, but there will be “no impact on NIH-funded work.” We have a problem with this response.
Effective for the May 2024 council round (peer review meetings in early 2024), all reviewers will be required to complete trainings related to review integrity and bias awareness prior to serving on NIH peer review groups. These trainings build on our long-standing commitment to maintaining integrity and fairness throughout the review process.
The HHS-declared public health emergency for COVID-19 ended on May 11, 2023 (NOT-OD-23-095). With this milestone, we are also closing out our series of blogs on the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the pandemic. This final post builds on previous … Continue reading “Final Career Stage Analyses of Applications Submitted During the Pandemic (Part 7)”